Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Molecular Templates Q2 2024 GAAP EPS $(1.23) Beats $(1.44) Estimate, Sales $572.00K Beat $430.00K Estimate

Author: Benzinga Newsdesk | August 14, 2024 04:30pm
Molecular Templates (NASDAQ:MTEM) reported quarterly losses of $(1.23) per share which beat the analyst consensus estimate of $(1.44) by 14.58 percent. The company reported quarterly sales of $572.00 thousand which beat the analyst consensus estimate of $430.00 thousand by 33.02 percent. This is a 91.67 percent decrease over sales of $6.87 million the same period last year.

Posted In: MTEM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist